C4X Discovery and PhoreMost collaborate to accelerate Parkinson’s disease drug discovery pipeline
LONDON: C4X Discovery Holdings plc (AIM: C4XD), a pioneering drug discovery company, entered into a collaboration with PhoreMost, a UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets. The collaboration,…